In 2016, by in vitro cell culture and in vivo xenograft approaches, it was clearly demonstrated that PDE5/cGMP/PKG signal targets to Hippo/TAZ pathway in maintaining stemness of prostate cancer stem cells, evidencing a novel role of PDE5 in governing stem cell features [218]. This evidence concerns the gene PDE5A and prostate carcinoma.